Loading
Apnimed, Inc. Stock: price and insider trades · United States
2 insiders bought €4.5M of shares over the last 90 days, the latest by Morningside Venture Investments Ltd, filed 05 Aug 2026.
Insider Decl.
25
Thresholds
n/a
Buy Volume
€5M
2 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleMorningside Venture Investments Ltd1 buy
Paul J. Sekhri1 buy
Since the insiders bought
- -32.2%Entry US$27.88 · Close 21 Oct 2026 US$18.90
- -26.5%Entry US$25.71 · Close 21 Oct 2026 US$18.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Apnimed, Inc. Strong Buy (bullish), based on 3 analysts. Average price target: US$50.33.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 17,620 of 26,246 companies
40.3
score / 100
Value24
Quality57
FCF yld-9.9%
Earn yld-0.1%
EV/EBITDA·
ROE·
Gross mgn83%
Net mgn-2.4%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$18.90
Analyst consensus
3 analystsStrong buy
US$41.00Target US$50.33(+166%)US$60.00
Income statement
RevenueUS$38.5M
Gross profitUS$31.8M83% margin
EBITDA-US$53.8M-140% margin
Net income-US$932k142.1% margin
Valuation
PER (trailing)2.6x
PER (forward)-4.8x
Balance sheet & cash
Market capUS$786.8M
Total debtUS$41.5M
Free Cash Flow-US$77.8M
Debt / Equity130%
Profitability & ownership
% insiders35.6%
% institutions25.0%
Last declaration on 5 August 2026
Declarations25 total
1,001,651 sharesCommon StockSEC:0000919574-26-004812:0
6,840,213 sharesClass A Common StockSEC:0000905148-26-003483:0
6,840,213 sharesClass A Common StockSEC:0000905148-26-003483:1
75,624 sharesClass A Common StockSEC:0000905148-26-003483:5
75,624 sharesCommon StockSEC:0000905148-26-003483:6
534,214 sharesCommon StockSEC:0000919574-26-004812:1
4,006,611 sharesCommon StockSEC:0000919574-26-004812:2
6,840,213 sharesCommon StockSEC:0000905148-26-003483:2
1,512,480 shares@ US$13.502.24% mcap100.0% of flowCommon StockSEC:0000919574-26-004812:3
312,500 shares@ US$16.000.55% mcap82.1% of flowCommon StockSEC:0000905148-26-003483:3
Canonical exit: 1 Nov 2026 (T+90)
75,624 shares@ US$14.400.12% mcap17.9% of flowClass A Common StockSEC:0000905148-26-003483:4
12,500 shares@ US$16.000.022% mcap100.0% of flowCommon StockSEC:0001193125-26-330507:0
Canonical exit: 1 Nov 2026 (T+90)
58,014 sharesClass A Common StockSEC:0001193125-26-330502:0
58,014 sharesCommon StockSEC:0001193125-26-330502:1
92,431 sharesClass A Common StockSEC:0001193125-26-330506:0
92,431 sharesCommon StockSEC:0001193125-26-330506:1
10,845 sharesCommon StockSEC:0001193125-26-330506:2
88,954 sharesClass A Common StockSEC:0001193125-26-330506:3
88,954 sharesCommon StockSEC:0001193125-26-330506:4
88,954 sharesClass A Common StockSEC:0001193125-26-330506:5
88,954 sharesCommon StockSEC:0001193125-26-330506:6
88,954 sharesClass A Common StockSEC:0001193125-26-330506:7
88,954 sharesCommon StockSEC:0001193125-26-330506:8
88,954 sharesClass A Common StockSEC:0001193125-26-330506:9
88,954 sharesCommon StockSEC:0001193125-26-330506:10
25 of 25 declarations
About Apnimed, Inc.
Everything in the record of Apnimed, Inc. fits in a very short window: 25 filings published from August 3 to 5, 2026, for trades all dated August 3, 2026. That day, two purchases were filed, for EUR 4,508,400: EUR 4,335,000 by Morningside Venture Investments Ltd (10% Owner) and EUR 173,400 by Paul J. Sekhri (Director). No sale is on file.
The other filings are grants (6) or of another kind (17), which fits the opening of a holdings history rather than market trades. Lawrence G. Miller (Director) filed 11 times with no purchase or sale; Alpha Wave Ventures GP, Ltd (10% Owner) filed 4 and Dennis Patrick Molnar (President) 2, likewise with no market trade.
Read moreShow less
Apnimed is a US health care and pharma company listed on Nasdaq, valued at USD 690.9 million, of which 35.6% is held by filers, among 5 filers. The history is too short to show a trend: the last twelve months repeat the same 25 filings. Filings are published the same day, as a median.
